Abdullah Sökmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdullah Sökmen has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Cemal Tuncer
Department of Cardiology, Kahramanmaras Sutcu Imam University, Faculty of Medicine, Kahramanmaras, Turkey
8 shared publications - Gurkan Acar
Department of Cardiology, Kahramanmaras Sutcu Imam University, Faculty of Medicine, Kahramanmaras, Turkey
8 shared publications Gülizar Sökmen
7 shared publications- Ahmet Akcay
Cardiology Department, Kahramanmaras Sutcu Imam University, Faculty of Medicine, Kahramanmaras, Turkey
6 shared publications Gulizar Sokmen
Department of Cardiology Faculty of Medicine Kahramanmaras Sutcu Imam University Kahramanmaras Turkey
6 shared publications- Murat Kerkütlüoğlu
Department of Cardiology, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş 46040, Türkiye
5 shared publications
Latest Publications
- Open Access
Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients
Background and objective: Prevalence of atrial fibrillation is higher in hemodialysis patients as compared to the general population. Atrial electromechanical delay is known as a significant predictor of atrial fibrillation. In this study, we aimed to reveal the relationship between atrial electromechanical delay and attacks of atrial fibrillation. Materials and methods: The study included 77 hemodialysis patients over 18 years of age giving written consent to participate in the study. The patients were divided into two groups based on the results of 24-h Holter Electrocardiogram (Holter ECG) as the ones having attacks of atrial fibrillation and the others without any attack of atrial fibrillation. Standard echocardiographic measurements were taken from all patients. Additionally, atrial conduction times were measured by tissue Doppler technique and atrial electromechanical delays were calculated. Results: Intra- and interatrial electromechanical delay were found as significantly lengthened in the group of patients with attacks of atrial fibrillation (p = 0.03 and p < 0.001 respectively). The optimal cut-off time for interatrial electromechanical delay to predict atrial fibrillation was >21 ms with a specificity of 79.3% and a sensitivity of 73.7% (area under the curve 0.820; 95% confidence interval (CI), 0.716–0.898). In the multivariate logistic regression model, interatrial electromechanical delay (odds ratio = 1.230; 95% CI, 1.104–1.370; p < 0.001) and hypertension (odds ratio = 4.525; 95% CI, 1.042–19.651; p = 0.044) were also associated with atrial fibrillation after adjustment for variables found to be statistically significant in univariate analysis and correlated with interatrial electromechanical delay. Conclusions: Interatrial electromechanical delay is independently related with the attacks of atrial fibrillation detected on Holter ECG records in hemodialysis patients.
Open AccessEvaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients
Background and objective: Prevalence of atrial fibrillation is higher in hemodialysis patients as compared to the general population. Atrial electromechanical delay is known as a significant predictor of atrial fibrillation. In this study, we aimed to reveal the relationship between atrial electromechanical delay and attacks of atrial fibrillation. Materials and methods: The study included 77 hemodialysis patients over 18 years of age giving written consent to participate in the study. The patients were divided into two groups based on the results of 24-h Holter Electrocardiogram (Holter ECG) as the ones having attacks of atrial fibrillation and the others without any attack of atrial fibrillation. Standard echocardiographic measurements were taken from all patients. Additionally, atrial conduction times were measured by tissue Doppler technique and atrial electromechanical delays were calculated. Results: Intra- and interatrial electromechanical delay were found as significantly lengthened in the group of patients with attacks of atrial fibrillation (p = 0.03 and p < 0.001 respectively). The optimal cut-off time for interatrial electromechanical delay to predict atrial fibrillation was >21 ms with a specificity of 79.3% and a sensitivity of 73.7% (area under the curve 0.820; 95% confidence interval (CI), 0.716–0.898). In the multivariate logistic regression model, interatrial electromechanical delay (odds ratio = 1.230; 95% CI, 1.104–1.370; p < 0.001) and hypertension (odds ratio = 4.525; 95% CI, 1.042–19.651; p = 0.044) were also associated with atrial fibrillation after adjustment for variables found to be statistically significant in univariate analysis and correlated with interatrial electromechanical delay. Conclusions: Interatrial electromechanical delay is independently related with the attacks of atrial fibrillation detected on Holter ECG records in hemodialysis patients.
- 1 April 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (8) , e86
Transcatheter Aortic Valve Implantation in Patients with a Large Aortic Annulus and Severe Aortic Regurgitation
- 1 April 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (8) , e86
Transcatheter Aortic Valve Implantation in Patients with a Large Aortic Annulus and Severe Aortic Regurgitation
- 1 April 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (8) , e90-e91
PP-149 [AJC » Cardiac pacing for bradyarrhythmias] Epicardial Permanent Pacemaker Implantation Via Coronary Sinus in a Patient With Bioprosthesis Tricuspid Valve
- 1 April 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (8) , e90-e91
PP-149 [AJC » Cardiac pacing for bradyarrhythmias] Epicardial Permanent Pacemaker Implantation Via Coronary Sinus in a Patient With Bioprosthesis Tricuspid Valve
- 1 April 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (8) , e82-e84
PP-174 [AJC » Peripheral arterial diseases] A Case of a Patient With Takayasu Arteritis Treated With Right and Left Subclavian Artery Stent Implantation
- 1 April 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (8) , e82-e84
PP-174 [AJC » Peripheral arterial diseases] A Case of a Patient With Takayasu Arteritis Treated With Right and Left Subclavian Artery Stent Implantation
- 1 April 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (8) , e53-e54
OP-123 [AJC » Pregnancy and Heart diseases] Coexistence of Peripartum Cardiomyopathy With Biventricular Thrombus and Acute Pulmonary Thromboembolism
- 1 April 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 119 (8) , e53-e54
OP-123 [AJC » Pregnancy and Heart diseases] Coexistence of Peripartum Cardiomyopathy With Biventricular Thrombus and Acute Pulmonary Thromboembolism
- Open Access
- 18 June 2016
- Published by Hatay Mustafa Kemal University Faculty of Medicine in Mustafa Kemal Üniversitesi Tıp Dergisi
- Vol. 7 (27)
BARİATRİK CERRAHİ İLE KİLO KAYBININ KARDİYAK FONKSİYONLARA ETKİSİNİN EKOKARDİYOGRAFİ İLE DEĞERLENDİRİLMESİ
- 18 June 2016
- Published by Hatay Mustafa Kemal University Faculty of Medicine in Mustafa Kemal Üniversitesi Tıp Dergisi
- Vol. 7 (27)
Open AccessBARİATRİK CERRAHİ İLE KİLO KAYBININ KARDİYAK FONKSİYONLARA ETKİSİNİN EKOKARDİYOGRAFİ İLE DEĞERLENDİRİLMESİ
- Open Access
- 11 June 2014
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 5 (2) , 265-270
Evaluation of diastolic function in patients with slow coronary flow by conventional and tissue Doppler echocardiography
- 11 June 2014
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 5 (2) , 265-270
Open AccessEvaluation of diastolic function in patients with slow coronary flow by conventional and tissue Doppler echocardiography
- 6 June 2013
- Published by Wiley in Echocardiography
- Vol. 30 (10) , 1194-1201
Evaluation of Atrial Electromechanical Delay and Diastolic Functions in Patients with Hyperthyroidism
Aim: Hyperthyroidism is a well‐known cause of atrial fibrillation (AF) which is associated with increased morbidity and mortality. Atrial electromechanical delay (EMD) is a significant predictor of AF. The aim of this study was to assess the atrial EMD and diastolic functions in subclinical and overt hyperthyroidism by using tissue Doppler imaging (TDI).Methods and Results: The study population consisted of 3 groups: group I (30 healthy subjects), group II (38 patients with subclinical hyperthyroidism), and group III (25 patients with overt hyperthyroidism). Atrial electromechanical coupling was measured with TDI. Standard echocardiographic measurements and parameters of diastolic function were obtained by conventional echocardiography and TDI.Intra‐ and inter‐atrial EMD were significantly prolonged in subclinical and overt hyperthyroidism compared with control group (P = 0.03 and P < 0.001 for intra‐atrial EMD; P < 0.001 for inter‐atrial EMD). In groups II and III, mitral A velocity (P = 0.005 and P = 0.001) and mitral E‐wave deceleration time (P < 0.001 and P = 0.02) were significantly increased, and mitral E/A ratio (P = 0.005 and P = 0.001) was significantly decreased compared with the control group. The lateral mitral Em/Am ratio in group II and group III was significantly lower than controls (P = 0.001). Mitral Em/Am ratio (β = −0.32, P = 0.002) and thyroid stimulating hormone (TSH) level (β = −0.27, P = 0.009) were negatively and independently correlated with inter‐atrial EMD.Conclusion: This study showed that intra‐ and inter‐atrial electromechanical intervals were prolonged and diastolic function was impaired in both overt and subclinical hyperthyroidism. TSH level and mitral Em/Am ratio were found as independent predictors of atrial EMD.
- 6 June 2013
- Published by Wiley in Echocardiography
- Vol. 30 (10) , 1194-1201
Evaluation of Atrial Electromechanical Delay and Diastolic Functions in Patients with Hyperthyroidism
Aim: Hyperthyroidism is a well‐known cause of atrial fibrillation (AF) which is associated with increased morbidity and mortality. Atrial electromechanical delay (EMD) is a significant predictor of AF. The aim of this study was to assess the atrial EMD and diastolic functions in subclinical and overt hyperthyroidism by using tissue Doppler imaging (TDI).Methods and Results: The study population consisted of 3 groups: group I (30 healthy subjects), group II (38 patients with subclinical hyperthyroidism), and group III (25 patients with overt hyperthyroidism). Atrial electromechanical coupling was measured with TDI. Standard echocardiographic measurements and parameters of diastolic function were obtained by conventional echocardiography and TDI.Intra‐ and inter‐atrial EMD were significantly prolonged in subclinical and overt hyperthyroidism compared with control group (P = 0.03 and P < 0.001 for intra‐atrial EMD; P < 0.001 for inter‐atrial EMD). In groups II and III, mitral A velocity (P = 0.005 and P = 0.001) and mitral E‐wave deceleration time (P < 0.001 and P = 0.02) were significantly increased, and mitral E/A ratio (P = 0.005 and P = 0.001) was significantly decreased compared with the control group. The lateral mitral Em/Am ratio in group II and group III was significantly lower than controls (P = 0.001). Mitral Em/Am ratio (β = −0.32, P = 0.002) and thyroid stimulating hormone (TSH) level (β = −0.27, P = 0.009) were negatively and independently correlated with inter‐atrial EMD.Conclusion: This study showed that intra‐ and inter‐atrial electromechanical intervals were prolonged and diastolic function was impaired in both overt and subclinical hyperthyroidism. TSH level and mitral Em/Am ratio were found as independent predictors of atrial EMD.
- 1 June 2010
- Vol. 38 (4) , 244-9
Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow.
Imbalance between oxidative stress and antioxidant defense has been demonstrated in patients with slow coronary flow (SCF). The aim of this study was to investigate the effect of nebivolol treatment on oxidative stress parameters in SCF patients. The study included 32 patients (10 females, 22 males; mean age 53.3 ± 5.2 years) with SCF and 32 control subjects (14 females, 18 males; mean age 50.6 ± 5.2 years) with normal coronary arteries on angiography. Coronary slow flow was determined by the TIMI frame count method. Patients with SCF received nebivolol treatment (5 mg/day) for six months. Blood samples were analyzed for malondialdehyde (MDA) and serum nitric oxide (NO) levels, and erythrocyte catalase (CAT) and erythrocyte superoxide dismutase (SOD) activities in the control group and, in SCF patients, at baseline and after six months of nebivolol treatment. The two groups were similar with respect to age, body mass index, blood pressure, heart rate, and lipid profile. Smoking was more frequent in the SCF group compared to the controls. TIMI frame counts measured from the left anterior descending, circumflex, and right coronary arteries were significantly higher in the SCF group (p < 0.0001). Baseline MDA and NO levels, and SOD and CAT activities were significantly different between the two groups, with significantly increased MDA (p < 0.0001), and significantly decreased SOD (p < 0.0001), CAT (p < 0.001), and NO (p < 0.001) in the SCF group. After six months of nebivolol treatment, all oxidative stress parameters showed significant improvements compared to the baseline values (p < 0.0001 for MDA, SOD, CAT, and NO) and approximated to the values of the control group. Our results show that nebivolol treatment may be beneficial to improve oxidative stress parameters in patients with SCF, which are considered to be an early stage of atherosclerosis.
- 1 June 2010
- Vol. 38 (4) , 244-9
Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow.
Imbalance between oxidative stress and antioxidant defense has been demonstrated in patients with slow coronary flow (SCF). The aim of this study was to investigate the effect of nebivolol treatment on oxidative stress parameters in SCF patients. The study included 32 patients (10 females, 22 males; mean age 53.3 ± 5.2 years) with SCF and 32 control subjects (14 females, 18 males; mean age 50.6 ± 5.2 years) with normal coronary arteries on angiography. Coronary slow flow was determined by the TIMI frame count method. Patients with SCF received nebivolol treatment (5 mg/day) for six months. Blood samples were analyzed for malondialdehyde (MDA) and serum nitric oxide (NO) levels, and erythrocyte catalase (CAT) and erythrocyte superoxide dismutase (SOD) activities in the control group and, in SCF patients, at baseline and after six months of nebivolol treatment. The two groups were similar with respect to age, body mass index, blood pressure, heart rate, and lipid profile. Smoking was more frequent in the SCF group compared to the controls. TIMI frame counts measured from the left anterior descending, circumflex, and right coronary arteries were significantly higher in the SCF group (p < 0.0001). Baseline MDA and NO levels, and SOD and CAT activities were significantly different between the two groups, with significantly increased MDA (p < 0.0001), and significantly decreased SOD (p < 0.0001), CAT (p < 0.001), and NO (p < 0.001) in the SCF group. After six months of nebivolol treatment, all oxidative stress parameters showed significant improvements compared to the baseline values (p < 0.0001 for MDA, SOD, CAT, and NO) and approximated to the values of the control group. Our results show that nebivolol treatment may be beneficial to improve oxidative stress parameters in patients with SCF, which are considered to be an early stage of atherosclerosis.
- 30 April 2010
- Published by Elsevier in International Journal of Cardiology
- Vol. 140, S81
PP-144 CORONARY EMBOLISM IN A PATIENT WITH DOUBLE PROSTHETIC VALVES WITHOUT VALVE THROMBOSIS
- 30 April 2010
- Published by Elsevier in International Journal of Cardiology
- Vol. 140, S81
PP-144 CORONARY EMBOLISM IN A PATIENT WITH DOUBLE PROSTHETIC VALVES WITHOUT VALVE THROMBOSIS